- Home
- ACHV vs POWW Comparison
ACHV vs POWW Comparison
Compare ACHV & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- POWW
- Stock Information
- Founded
- ACHV N/A
- POWW 1990
- Country
- ACHV Canada
- POWW United States
- Employees
- ACHV N/A
- POWW N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- POWW Ordnance And Accessories
- Sector
- ACHV Health Care
- POWW Industrials
- Exchange
- ACHV Nasdaq
- POWW Nasdaq
- Market Cap
- ACHV 137.6M
- POWW 154.4M
- IPO Year
- ACHV N/A
- POWW N/A
- Fundamental
- Price
- ACHV $3.69
- POWW $0.98
- Analyst Decision
- ACHV Strong Buy
- POWW Hold
- Analyst Count
- ACHV 5
- POWW 1
- Target Price
- ACHV $14.80
- POWW $1.50
- AVG Volume (30 Days)
- ACHV 142.3K
- POWW 784.7K
- Earning Date
- ACHV 11-07-2024
- POWW 02-06-2025
- Dividend Yield
- ACHV N/A
- POWW N/A
- EPS Growth
- ACHV N/A
- POWW N/A
- EPS
- ACHV N/A
- POWW N/A
- Revenue
- ACHV N/A
- POWW $135,498,023.00
- Revenue This Year
- ACHV N/A
- POWW $5.67
- Revenue Next Year
- ACHV N/A
- POWW $4.86
- P/E Ratio
- ACHV N/A
- POWW N/A
- Revenue Growth
- ACHV N/A
- POWW N/A
- 52 Week Low
- ACHV $3.41
- POWW $0.96
- 52 Week High
- ACHV $5.59
- POWW $2.94
- Technical
- Relative Strength Index (RSI)
- ACHV 26.02
- POWW 31.89
- Support Level
- ACHV $4.07
- POWW $1.12
- Resistance Level
- ACHV $4.21
- POWW $1.08
- Average True Range (ATR)
- ACHV 0.22
- POWW 0.06
- MACD
- ACHV -0.06
- POWW -0.02
- Stochastic Oscillator
- ACHV 8.49
- POWW 11.00
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About POWW AMMO Inc.
AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.